Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Fast Track Articles
  5. Fast Track Article
image of Sanggenol L Alleviates Rotenone-induced Parkinson's Disease and Inhibits Mitochondrial Complex I by Apoptosis Via P13K/AKT/mTOR Signalling

Abstract

Background

Parkinson’s disease (PD) is the age-associated, second most advanced neurodegenerative illness. Rotenone is an extensively used pesticide to study PD pathology and inhibits mitochondrial complex I. Reports indicate that rotenone exerts neurotoxicity by its capability to produce reactive oxygen species (ROS), which eventually leads to neuronal apoptosis.

Objective

Sanggenol L (SL) is an eminent flavonoid present in the Morus alba root bark, which exhibits neuroprotective, anticancer, and antioxidant properties. Materials and Methods: Hence, we assessed the neuroprotective activity of SL (5 and 10 µM/ml) on rotenone-stimulated SK-N-SH neuroblastoma cells and elucidated the effect of the P13K/AKT/mTOR signalling.

Results

The anti-PD action of SL on proliferation, oxidative stress (OS), intracellular ROS, apoptosis, Bax, cleaved Caspase-12, -9, -3, and Cyt-c, Bcl-2 and P13K/AKT/mTOR signaling was determined by MTT assay, biochemical analysis, DCFDA, AO/EB staining and western blot. It was found that SL (5 and 10 µM/ml) reduced rotenone-triggered OS, ROS levels, and apoptosis in a concentration-related way. SL alleviates Bax, cleaved caspase-12, -9, -3, and Cyt-c, while reducing Bcl-2. Furthermore, SL safer mitochondria by increase MMP and suppresses phosphorylation of P13k/AKT/mTOR pathway, thereby regulating apoptotic signalling.

Conclusion

Our findings indicate that SL showed protective effects against rotenone-induced OS, mitochondrial complex-I in neuronal cell damage, which suggests that SL might potentially serve as an anti-PD remedial candidate for PD treatment.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073358649241128053921
2024-12-13
2025-03-01

  • From This Site

    /content/journals/cchts/10.2174/0113862073358649241128053921
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Agafonova I. Chingizova E. Chaikina E. Menchinskaya E. Kozlovskiy S. Likhatskaya G. Sabutski Y. Polonik S. Aminin D. Pislyagin E. Protection activity of 1,4-naphthoquinones in rotenone-induced models of neurotoxicity. Mar. Drugs 2024 22 2 62 10.3390/md22020062 38393033
    [Google Scholar]
  2. Werner M.H. Olanow C.W. Parkinson’s disease modification through abl kinase inhibition: An opportunity. Mov. Disord. 2022 37 1 6 15 10.1002/mds.28858 34816484
    [Google Scholar]
  3. Raza C. Anjum R. Shakeel N.A. Parkinson’s disease: Mechanisms, translational models and management strategies. Life Sci. 2019 226 77 90 10.1016/j.lfs.2019.03.057 30980848
    [Google Scholar]
  4. Dionísio P.A. Amaral J.D. Rodrigues C.M.P. Oxidative stress and regulated cell death in Parkinson’s disease. Ageing Res. Rev. 2021 67 101263 10.1016/j.arr.2021.101263 33540042
    [Google Scholar]
  5. Chakrabarti S. Bisaglia M. Oxidative stress and neuroinflammation in Parkinson’s disease: The role of dopamine oxidation products. Antioxidants 2023 12 4 955 10.3390/antiox12040955 37107329
    [Google Scholar]
  6. El-Latif A.M.A. Rabie M.A. Sayed R.H. Fattah M.A.A.E. Kenawy S.A. Inosine attenuates rotenone‐induced Parkinson’s disease in rats by alleviating the imbalance between autophagy and apoptosis. Drug Dev. Res. 2023 84 6 1159 1174 10.1002/ddr.22077 37170799
    [Google Scholar]
  7. Dong W. Zhong J. Chen Y. Xie J. Qin Y. Xu J. Cai N. Li M. Liu L. Wang H. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson’s disease models. Acta Pharmacol. Sin. 2021 42 12 1991 2003 10.1038/s41401‑021‑00768‑4 34531546
    [Google Scholar]
  8. Hassanzadeh K. Rahimmi A. Oxidative stress and neuroinflammation in the story of Parkinson’s disease: Could targeting these pathways write a good ending? J. Cell. Physiol. 2019 234 1 23 32 10.1002/jcp.26865 30078201
    [Google Scholar]
  9. Hu M. Li F. Wang W. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway. Drug Des. Devel. Ther. 2018 12 565 573 10.2147/DDDT.S156920 29588573
    [Google Scholar]
  10. Desouky M.A. George M.Y. Michel H.E. Elsherbiny D.A. Roflumilast escalates α-synuclein aggregate degradation in rotenone-induced Parkinson’s disease in rats: Modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress. Chem. Biol. Interact. 2023 379 110491 10.1016/j.cbi.2023.110491 37105514
    [Google Scholar]
  11. Campolo M. Casili G. Biundo F. Crupi R. Cordaro M. Cuzzocrea S. Esposito E. The neuroprotective effect of dimethyl fumarate in an MPTP-mouse model of Parkinson’s Disease: Involvement of reactive oxygen species/nuclear factor-κb/nuclear transcription factor related to NF-E2. Antioxid. Redox Signal. 2017 27 8 453 471 10.1089/ars.2016.6800 28006954
    [Google Scholar]
  12. Zhu J. Dou S. Jiang Y. Bai B. Chen J. Wang C. Cheng B. Apelin-36 exerts the cytoprotective effect against MPP+-induced cytotoxicity in SH-SY5Y cells through PI3K/Akt/mTOR autophagy pathway. Life Sci. 2019 224 95 108 10.1016/j.lfs.2019.03.047 30905782
    [Google Scholar]
  13. Zhao Y. Han Y. Wang Z. Chen T. Qian H. He J. Li J. Han B. Wang T. Rosmarinic acid protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in zebrafish embryos. Toxicol. In Vitro 2020 65 104823 10.1016/j.tiv.2020.104823 32147576
    [Google Scholar]
  14. Babaei M. Borja Zamfir G.M. Chen X. Christensen H.B. Kristensen M. Nielsen J. Borodina I. Metabolic engineering of Saccharomyces cerevisiae for rosmarinic acid production. ACS Synth. Biol. 2020 9 8 1978 1988 10.1021/acssynbio.0c00048 32589831
    [Google Scholar]
  15. Nam M.S. Jung D.B. Seo K.H. Kim B.I. Kim J.H. Kim J.H. Kim B. Baek N.I. Kim S.H. Apoptotic effect of sanggenol L via caspase activation and inhibition of NF-κB signaling in ovarian cancer cells. Phytother. Res. 2016 30 1 90 96 10.1002/ptr.5505 26555861
    [Google Scholar]
  16. Wang H. Jin T. Mao Y. Wei Y. Sanggenol L. Sanggenol L reduces LPS-induced myocardial injury and inflammation by activating PI3K/AKT/mTOR and inhibiting NF-κB in rats. Pharmacogn. Mag. 2024 2024 09731296241264617 10.1177/09731296241264617
    [Google Scholar]
  17. Jung J.W. Ko W.M. Park J.H. Seo K.H. Oh E.J. Lee D.Y. Lee D.S. Kim Y.C. Lim D.W. Han D. Baek N.I. Isoprenylated flavonoids from the root bark of Morus alba and their hepatoprotective and neuroprotective activities. Arch. Pharm. Res. 2015 38 11 2066 2075 10.1007/s12272‑015‑0613‑8 25981820
    [Google Scholar]
  18. Fu Q. Zhang F. Vijayalakshmi A. The protective effect of Sanggenol L against DMBA-induced hamster buccal pouch carcinogenesis induces apoptosis and inhibits cell proliferative signalling pathway. Comb. Chem. High Throughput Screen. 2024 27 6 885 893 10.2174/1386207326666230726140706 37496247
    [Google Scholar]
  19. Sun C. Liu R. Wang X. Velu P. Vijayalakshmi A. Guan Q. Sanggenol L. Alleviates inflammation and ankles joint destruction through the suppression of the P13K/AKT pathway in arthritis prompted by type ii collagen in experimental rats. Lat. Am. J. Pharm. 2023 42 1002 1008
    [Google Scholar]
  20. Won Y.S. Seo K.I. Sanggenol L. Sanggenol L induces apoptosis and cell cycle arrest via activation of p53 and suppression of PI3K/Akt/mTOR signaling in human prostate cancer cells. Nutrients 2020 12 2 488 10.3390/nu12020488 32075054
    [Google Scholar]
  21. Heinz S. Freyberger A. Lawrenz B. Schladt L. Schmuck G. Ellinger-Ziegelbauer H. Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation. Sci. Rep. 2017 7 1 45465 10.1038/srep45465 28374803
    [Google Scholar]
  22. Erro R. Mencacci N.E. Bhatia K.P. The emerging role of phosphodiesterases in movement disorders. Mov. Disord. 2021 36 10 2225 2243 10.1002/mds.28686 34155691
    [Google Scholar]
  23. Feng H. Xi F. Miltirone attenuates reactive oxygen species-dependent neuronal apoptosis in MPP+-Induced cell model of parkinson’s disease through regulating the PI3K/Akt pathway. Neurochem. Res. 2022 47 10 3137 3149 10.1007/s11064‑022‑03669‑y 35810264
    [Google Scholar]
  24. Treviño S. Flores I.O. Díaz A. Neurotrophic fragments as therapeutic alternatives to ameliorate brain aging. Neural Regen. Res. 2023 18 1 51 56 10.4103/1673‑5374.331867 35799508
    [Google Scholar]
  25. Moors T.E. Hoozemans J.J.M. Ingrassia A. Beccari T. Parnetti L. Chartier-Harlin M.C. van de Berg W.D.J. Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease. Mol. Neurodegener. 2017 12 1 11 10.1186/s13024‑017‑0154‑3 28122627
    [Google Scholar]
  26. Goyal A. Agrawal A. Verma A. Dubey N. The PI3K-AKT pathway: A plausible therapeutic target in Parkinson’s disease. Exp. Mol. Pathol. 2023 129 104846 10.1016/j.yexmp.2022.104846 36436571
    [Google Scholar]
  27. Yao Z. Li J. Bian L. Li Q. Wang X. Yang X. Wei X. Wan G. Wang Y. Shi J. Guo J. Nootkatone alleviates rotenone‐induced Parkinson’s disease symptoms through activation of the PI3K /Akt signaling pathway. Phytother. Res. 2022 36 11 4183 4200 10.1002/ptr.7552 35833337
    [Google Scholar]
  28. Li Y. Pang J. Wang J. Dai G. Bo Q. Wang X. Wang W. Knockdown of PDCD4 ameliorates neural cell apoptosis and mitochondrial injury through activating the PI3K/AKT/mTOR signal in Parkinson’s disease. J. Chem. Neuroanat. 2023 129 102239 10.1016/j.jchemneu.2023.102239 36736747
    [Google Scholar]
  29. Wang Q. Shen Z.N. Zhang S.J. Sun Y. Zheng F.J. Li Y.H. Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases. Front. Pharmacol. 2022 13 1022053 10.3389/fphar.2022.1022053 36353499
    [Google Scholar]
  30. Zhang S. Wu P. Liu J. Du Y. Yang Z. Roflumilast attenuates doxorubicin-induced cardiotoxicity by targeting inflammation and cellular senescence in cardiomyocytes mediated by SIRT1. Drug Des. Devel. Ther. 2021 15 87 97 10.2147/DDDT.S269029 33469262
    [Google Scholar]
  31. Peng T. Liu X. Wang J. Liu Y. Fu Z. Ma X. Li J. Sun G. Ji Y. Lu J. Wan W. Lu H. RETRACTED ARTICLE: Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson’s disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation. Artif. Cells Nanomed. Biotechnol. 2019 47 1 2764 2774 10.1080/21691401.2019.1636805 31298038
    [Google Scholar]
  32. Ren R. Shi C. Cao J. Sun Y. Zhao X. Guo Y. Wang C. Lei H. Jiang H. Ablat N. Xu J. Li W. Ma Y. Qi X. Ye M. Pu X. Han H. Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson’s Disease. Sci. Rep. 2016 6 1 22135 10.1038/srep22135 26906725
    [Google Scholar]
  33. Tamilselvam K. Braidy N. Manivasagam T. Essa M.M. Prasad N.R. Karthikeyan S. Thenmozhi A.J. Selvaraju S. Guillemin G.J. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson’s disease. Oxid. Med. Cell. Longev. 2013 2013 1 11 10.1155/2013/102741 24205431
    [Google Scholar]
  34. Jiang D. Peng Y. The protective effect of decoction of Rehmanniae via PI3K/Akt/mTOR pathway in MPP + -induced Parkinson’s disease model cells. J. Recept. Signal Transduct. Res. 2021 41 1 74 84 10.1080/10799893.2020.1787445 32611232
    [Google Scholar]
  35. Velu P. Vijayalakshmi A. Vinothkumar V. Retracted: Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131. J. Pharm. Pharmacol. 2020 72 11 1595 1606 10.1111/jphp.13350 32790092
    [Google Scholar]
  36. Qin J. Fan M. He J. Wu X.D. Peng L.Y. Su J. Cheng X. Li Y. Kong L.M. Li R.T. Zhao Q.S. New cytotoxic and anti-inflammatory compounds isolated from Morus alba L. Nat. Prod. Res. 2015 29 18 1711 1718 10.1080/14786419.2014.999333 25675363
    [Google Scholar]
  37. Alfei S. Schito G.C. Schito A.M. Zuccari G. Reactive Oxygen Species (ROS)-mediated antibacterial oxidative therapies: Available methods to generate ROS and a novel option proposal. Int. J. Mol. Sci. 2024 25 13 7182 10.3390/ijms25137182 39000290
    [Google Scholar]
  38. Gutiérrez I.M.T. García S.N. Ibarra O.M. Rotenone-induced model of Parkinson’s disease: Beyond mitochondrial complex I inhibition. Mol. Neurobiol. 2023 60 4 1929 1948 10.1007/s12035‑022‑03193‑8 36593435
    [Google Scholar]
  39. El-Shamarka M.E. Abdel-Salam O.M. Shafee N. Zeidan H.M. Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease. Iran. J. Basic Med. Sci. 2023 26 2 139 147 10.22038/IJBMS.2022.61687.13650 36742141
    [Google Scholar]
  40. Grootveld M. Evidence-based challenges to the continued recommendation and use of peroxidatively-susceptible polyunsaturated fatty acid-rich culinary oils for high-temperature frying practises: Experimental revelations focused on toxic aldehydic lipid oxidation products. Front. Nutr. 2022 8 711640 10.3389/fnut.2021.711640 35071288
    [Google Scholar]
  41. Juan C.A. Pérez de la Lastra J.M. Plou F.J. Pérez-Lebeña E. The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int. J. Mol. Sci. 2021 22 9 4642 10.3390/ijms22094642 33924958
    [Google Scholar]
  42. Li H. Xue X. Li L. Li Y. Wang Y. Huang T. Wang Y. Meng H. Pan B. Niu Q. Aluminum-induced synaptic plasticity impairment via PI3K-Akt-mTOR signaling pathway. Neurotox. Res. 2020 37 4 996 1008 10.1007/s12640‑020‑00165‑5 31970651
    [Google Scholar]
  43. Li W. Yin X. Yan Y. Liu C. Li G. Kurarinone attenuates hydrogen peroxide‐induced oxidative stress and apoptosis through activating the PI3K /Akt signaling by upregulating IGF1 expression in human ovarian granulosa cells. Environ. Toxicol. 2023 38 1 28 38 10.1002/tox.23659 36114797
    [Google Scholar]
  44. Wu X. Liang Y. Jing X. Lin D. Chen Y. Zhou T. Peng S. Zheng D. Zeng Z. Lei M. Huang K. Tao E. Rifampicin prevents SH-SY5Y cells from rotenone-induced apoptosis via the PI3K/Akt/GSK-3β/CREB signaling pathway. Neurochem. Res. 2018 43 4 886 893 10.1007/s11064‑018‑2494‑y 29435803
    [Google Scholar]
  45. Zorova L.D. Popkov V.A. Plotnikov E.Y. Silachev D.N. Pevzner I.B. Jankauskas S.S. Babenko V.A. Zorov S.D. Balakireva A.V. Juhaszova M. Sollott S.J. Zorov D.B. Mitochondrial membrane potential. Anal. Biochem. 2018 552 50 59 10.1016/j.ab.2017.07.009 28711444
    [Google Scholar]
  46. Zorov D.B. Juhaszova M. Sollott S.J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 2014 94 3 909 950 10.1152/physrev.00026.2013 24987008
    [Google Scholar]
  47. Yadav S.K. Rai S.N. Singh S.P. Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model. J. Chem. Neuroanat. 2017 80 1 10 10.1016/j.jchemneu.2016.11.009 27919828
    [Google Scholar]
  48. Rai S.N. Yadav S.K. Singh D. Singh S.P. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J. Chem. Neuroanat. 2016 71 41 49 10.1016/j.jchemneu.2015.12.002 26686287
    [Google Scholar]
  49. Prakash J. Chouhan S. Yadav S.K. Westfall S. Rai S.N. Singh S.P. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem. Res. 2014 39 12 2527 2536 10.1007/s11064‑014‑1443‑7 25403619
    [Google Scholar]
  50. Ramakrishna K. Nalla L.V. Naresh D. Venkateswarlu K. Viswanadh M.K. Nalluri B.N. Chakravarthy G. Duguluri S. Singh P. Rai S.N. Kumar A. Singh V. Singh S.K. WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: Current status and future perspective. Diseases 2023 11 3 89 10.3390/diseases11030089 37489441
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073358649241128053921
Loading
Sanggenol L Alleviates Rotenone-induced Parkinson's Disease and Inhibits Mitochondrial Complex I by Apoptosis Via P13K/AKT/mTOR Signalling
Bentham Science Publishers ; https://doi.org/10.2174/0113862073358649241128053921
/content/journals/cchts/10.2174/0113862073358649241128053921
/content/journals/cchts/10.2174/0113862073358649241128053921
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: rotenone ; P13K/AKT/mTOR ; apoptosis ; parkinson’s disease ; oxidative stress ; Sanggenol L

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test